Philip Morris International submitted a Modified Risk Tobacco Product (MRTP) application for IQOS to the FDA on Dec. 5, 2016. Philip Morris International submitted a Pre-Market Tobacco Product Application (PMTA) for IQOS on March 31, 2017 and it received authorization from the FDA to sell and market IQOS in the U.S. on April 30, 2019. On March 30, 2020, Philip Morris International submitted a supplemental PMTA to the FDA for the IQOS3.
For all the latest news from Altria Group, visit altria.com.
